Maximal paraprotein decline with PS-341 alone.
| ITT Population (n = 70)* . | n (%) . | Cumulative (%) . |
|---|---|---|
| * 8 patients with either nonsecretory myeloma or missing data. | ||
| Complete or partial response | ||
| >90% reduction | 14 (20) | 20 |
| ≥75% reduction | 7(10) | 30 |
| ≥50% reduction | 6 (9) | 39 |
| ≥25 reduction | 6 (9) | 47 |
| No change | 21 (30) | 77 |
| PD (≥25% increase) | 12 (17) | |
| Non-evaluable | 4 (6) | |
| ITT Population (n = 70)* . | n (%) . | Cumulative (%) . |
|---|---|---|
| * 8 patients with either nonsecretory myeloma or missing data. | ||
| Complete or partial response | ||
| >90% reduction | 14 (20) | 20 |
| ≥75% reduction | 7(10) | 30 |
| ≥50% reduction | 6 (9) | 39 |
| ≥25 reduction | 6 (9) | 47 |
| No change | 21 (30) | 77 |
| PD (≥25% increase) | 12 (17) | |
| Non-evaluable | 4 (6) | |